UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 412

Sortiert nach

Challenges of Guarantee-Time Bias

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2963-2969

2013

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1485-1505

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Breast (Edinburgh), 2022-04, Vol.62, p.179-179

Regan, Meredith M.

2022

Link zum Volltext

Verfügbarkeit prüfen

Accelerating progress to innovation for patients: Trial design and risk stratification

Breast (Edinburgh), 2022-03, Vol.62 (Suppl 1), p.S80-S83

Regan, Meredith M.

2022

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Archives of pathology & laboratory medicine (1976), 2020-05, Vol.144 (5), p.545-563

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Journal of clinical oncology, 2009-12, Vol.27 (34), p.5794-5799

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98

Breast cancer research : BCR, 2019-02, Vol.21 (1), p.30-11, Article 30

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial

Fertility and sterility, 2010-08, Vol.94 (3), p.888-899

2010

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1179-1188

2017

Link zum Volltext

Verfügbarkeit prüfen

8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (21), p.9742-9746

2010

Link zum Volltext

Verfügbarkeit prüfen

Prediction of erectile function following treatment for prostate cancer

JAMA : the journal of the American Medical Association, 2011-09, Vol.306 (11), p.1205

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

Journal of the American College of Cardiology, 2004-02, Vol.43 (4), p.678-683

2004

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of germline variants in inflammatory breast cancer

Cancer, 2019-07, Vol.125 (13), p.2194-2202

2019

Link zum Volltext

Verfügbarkeit prüfen

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

Urologic oncology, 2013-07, Vol.31 (5), p.566-571

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

Cancer, 2014-04, Vol.120 (7), p.1076-1082

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

Clinical cancer research, 2009-07, Vol.15 (14), p.4706-4711

2009

Link zum Volltext

Verfügbarkeit prüfen

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3967-3975

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 412

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(378)

Publikationsform

Sprache

Englisch
(412)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(250)
Humans
(230)
Oncology
(160)
Female
(139)
Middle Aged
(109)
Male
(108)
Biological And Medical Sciences
(96)
Aged
(95)
Adult
(89)
Medical Sciences
(82)
Breast Cancer
(78)
Tumors
(67)
Breast Neoplasms - Drug Therapy
(62)
Treatment Outcome
(48)
Chemotherapy, Adjuvant
(45)
Prognosis
(39)
Clinical Trials
(37)
Antineoplastic Agents, Hormonal - Therapeutic Use
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(94)
The American Journal Of Clinical Nutrition
(32)
Cancer Research
(21)
Cancer
(15)
The Lancet Oncology
(14)
Breast
(13)
Clinical Cancer Research
(13)
Breast Cancer Research And Treatment
(12)
Npj Breast Cancer
(11)
The Journal Of Urology
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Challenges of Guarantee-Time Bias

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Accelerating progress to innovation for patients: Trial design and risk stratification

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Prediction of erectile function following treatment for prostate cancer

Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Prevalence of germline variants in inflammatory breast cancer

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

Suchergebnisse filtern